ResMed (RMD)
(Delayed Data from NYSE)
$226.64 USD
+3.23 (1.45%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $226.64 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
- YR Estimate
- 06/30/2024
- 06/30/2023
- 06/30/2022
- 06/30/2021
- 06/30/2020
- Revenue - Line of Business (LOBR)
- Global revenue: Devices
- 2,444.00
- 2,270.70
- 1,866.90
- 1,610.00
- 1,507.82
- Revenue - Line of Business (LOBR)
- Global revenue: Masks
- 1,657.20
- 1,454.30
- 1,310.40
- 1,213.20
- 1,094.56
- Revenue - Line of Business (LOBR)
- Global revenue: Total Sleep and Respiratory Care
- 4,101.20
- 3,725.00
- 3,177.30
- 2,823.20
- 2,602.38
- Revenue - Line of Business (LOBR)
- Global revenue: Software as a Service
- 584.10
- 498.00
- 400.80
- 373.60
- 354.63
- Revenue - Geographic (GEOR)
- U.S., Canada, and Latin America: Devices
- 1,522.80
- 1,444.40
- 1,070.40
- 863.70
- 792.77
- Revenue - Geographic (GEOR)
- U.S., Canada, and Latin America: Masks
- 1,199.80
- 1,039.00
- 911.40
- 841.50
- 779.56
- Revenue - Geographic (GEOR)
- U.S., Canada, and Latin America: Total
- 2,722.60
- 2,483.40
- 1,981.81
- 1,705.11
- 1,926.96
- Revenue - Geographic (GEOR)
- Combined Europe, Asia, and other markets: Devices
- 921.30
- 826.30
- 796.50
- 746.40
- 715.06
- Revenue - Geographic (GEOR)
- Combined Europe, Asia, and other markets: Masks
- 457.40
- 415.30
- 399.00
- 371.70
- 315.00
- Revenue - Geographic (GEOR)
- Combined Europe, Asia, and other markets: Total Sleep and Respiratory Care
- 1,378.60
- 1,241.60
- 1,195.50
- 1,118.10
- 1,030.05